892 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
21 Unknown  Efavirenz in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: efavirenz
22 Recruiting Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: Stereotactic Radiosurgery using the Novalis Tx
23 Unknown  The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
Condition: Castration-resistant Prostate Cancer
Interventions: Drug: ADT;   Drug: No ADT
24 Recruiting A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Conditions: Metastatic Castration-resistant Prostate Cancer;   Metastatic Breast Cancer
Intervention: Drug: Abiraterone acetate
25 Recruiting A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer
Condition: Prostate Cancer
Intervention: Behavioral: Couples Prostate Cancer Support Group
26 Recruiting Monitoring Anti-Prostate Cancer Immunity Following Stereotactic Body Radiotherapy (SBRT)
Condition: Oligometastatic Prostate Cancer
27 Recruiting Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Procedure: Radical Prostatectomy
28 Not yet recruiting Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Behavioral: behavioral dietary intervention;   Dietary Supplement: omega-3 fatty acid;   Other: laboratory biomarker analysis
29 Recruiting Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: androgen ablation + dendritic cell vaccine;   Biological: androgen ablation plus dendritic cell vaccine
30 Unknown  Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic Castration Resistant Prostate Cancer
Conditions: Metastatic Prostate Cancer;   Bone Metastasis
Intervention: Drug: Zoledronic acid
31 Not yet recruiting Continuous Monitoring of Prostate Position During Radiotherapy
Condition: Prostate Cancer
Intervention: Radiation: Prostate cancer radiotherapy gating using kV intrafraction monitoring (KIM)
32 Recruiting Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Extended Hypofractionation Radiotherapy;   Radiation: Accelerated Hypofractionation Radiotherapy;   Procedure: Fiducial Marker Placement;   Behavioral: Quality of Life Questionnaires;   Procedure: Prostate Biopsy;   Genetic: Biopsy Tissue for Biomarkers;   Genetic: Biofluids for proteomics and genomics studies
33 Recruiting Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
Conditions: Solid Tumors;   Breast Cancer;   Non-small Cell Lung Cancer;   Prostate Cancer;   Gastric Cancer
Interventions: Drug: Docetaxel;   Drug: Sunitinib
34 Recruiting Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer
Condition: Prostate Cancer
Intervention: Radiation: hypofractionation
35 Not yet recruiting Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients
Conditions: Benign Prostate Hyperplasia;   Urinary Retention
Interventions: Procedure: Green light PVP;   Procedure: Prostatic artery embolization
36 Recruiting Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status
Condition: Prostatic Neoplasms
Interventions: Procedure: PET-MR 18f-FACBC;   Procedure: histology (gold standard)
37 Recruiting Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis
Condition: Prostate Cancer
Intervention: Drug: Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone
38 Recruiting An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin
Conditions: Breast Cancer;   Healthy Volunteer;   Prostate Cancer
39 Recruiting Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate Cancer
Conditions: Bone Metastases;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Soft Tissue Metastases;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
40 Recruiting Multi-Institutional Registry for Prostate Cancer Radiosurgery
Conditions: Prostate Cancer Early Risk Treated by Radiosurgery;   Prostate Cancer Intermediate Risk Treated by Radiosurgery

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years